top of page
Psychiatric Services of Prescott Ketamine

Our Conclusion

Ketamine therapy represents a significant advancement in the treatment of depression and PTSD, offering rapid relief for individuals who have struggled with traditional approaches. By working closely with medical professionals and integrating psychotherapy, patients can harness the full potential of ketamine to achieve lasting mental health improvements.

Benefits of Ketamine Therapy

Rapid Relief for Depression and PTSD:

Clinical studies have shown that ketamine can significantly reduce symptoms of depression and PTSD within hours of administration. This rapid action is particularly beneficial for individuals experiencing suicidal ideation or severe distress.

Effective for Treatment-Resistant Cases:

For patients who have not responded to traditional therapies, ketamine offers a new avenue of hope. Its unique mechanism can break through the barriers that render other treatments ineffective.

Ketamine operates differently from conventional antidepressants. It primarily acts as an N-methyl-D-aspartate (NMDA) receptor antagonist, modulating the brain's glutamate system. This modulation promotes synaptic plasticity and the formation of new neural connections, which are believed to underlie its rapid antidepressant effects. Additionally, ketamine influences other pathways, including the mammalian target of rapamycin (mTOR) and brain-derived neurotrophic factor (BDNF), further supporting its role in mood regulation.

How does ketamine work?

Ketamine Treatment in Prescott Arizona

Katamine Infusion Therapy

YOUR PAST DOES NOT DEFINE YOU

About Ketamine Treatment

Ketamine, originally developed as an anesthetic in the 1960s, has emerged as a promising treatment for mental health conditions, particularly treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). Unlike traditional antidepressants, which may take weeks to show effects, ketamine can provide rapid relief, often within hours. It is typically administered in controlled clinical settings through intravenous (IV) infusions or intranasal sprays, such as the FDA-approved esketamine (Spravato).

bottom of page